PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial ...

Retrieved on: 2024-09-16 12:32:19

Tags for this article:

Click the tags to see associated articles and topics

PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial .... View article details on hiswai:

Excerpt

... immune response,” said Dr. Kirk Shepard, M.D., Chief Medical Officer of PDS Biotech. “The encouraging patient survival and clinical responses ...

Article found on: www.biospace.com